CircHIPK3 regulates cardiac fibroblast proliferation, migration and phenotypic switching through the

Weiwei Liu1, Yan Wang1, Zhimei Qiu1

  • 1Department of Cardiology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.

Peerj
|September 9, 2020
PubMed

Insights

Circular RNA HIPK3 (circHIPK3) promotes cardiac fibrosis under hypoxia by sponging miR-152-3p and upregulating TGF-β2. Modulating circHIPK3 may offer a therapeutic target for hypoxia-induced cardiac remodeling.

Area of Science:

  • Cardiovascular Biology
  • Molecular Biology
  • Epigenetics

Background:

  • Pathological cardiac fibrosis is linked to tissue hypoxia.
  • Circular RNAs (circRNAs) are key regulators in cardiovascular diseases.
  • CircHIPK3 is implicated in cardiac fibrosis, but its hypoxia-related mechanisms are unknown.

Purpose of the Study:

  • To determine circHIPK3 expression in cardiac fibroblasts (CFs) under hypoxia.
  • To investigate the functional role of circHIPK3 in CFs within a hypoxic environment.
  • To elucidate the molecular mechanisms underlying circHIPK3-mediated cardiac fibrosis.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) for circHIPK3 expression analysis.
  • Cell proliferation (EdU), migration (wound scratch), and cell cycle assays.
  • Immunofluorescence, Western blot, bioinformatics, dual luciferase, and RNA FISH assays to identify molecular interactions.

Main Results:

  • CircHIPK3 expression significantly increased in CFs under hypoxia.
  • Overexpression of circHIPK3 promoted CF proliferation, migration, and phenotypic changes; silencing had the opposite effect.
  • CircHIPK3 functions as a miR-152-3p sponge, with miR-152-3p targeting TGF-β2.

Conclusions:

  • CircHIPK3 promotes hypoxia-induced cardiac fibrosis by regulating the miR-152-3p/TGF-β2 axis.
  • CircHIPK3 influences CF proliferation, migration, and transformation to myofibroblasts.
  • Targeting circHIPK3 presents a potential therapeutic strategy for cardiac fibrosis.
Abstract